BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15975052)

  • 1. Amyloid beta-peptide: the inside story.
    Tseng BP; Kitazawa M; LaFerla FM
    Curr Alzheimer Res; 2004 Nov; 1(4):231-9. PubMed ID: 15975052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
    Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
    Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
    Askanas V; Engel WK
    J Neuropathol Exp Neurol; 2001 Jan; 60(1):1-14. PubMed ID: 11202170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
    Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
    Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
    Vattemi G; Engel WK; McFerrin J; Askanas V
    J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.
    Hoozemans JJ; Chafekar SM; Baas F; Eikelenboom P; Scheper W
    Curr Med Chem; 2006; 13(22):2599-605. PubMed ID: 17017913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic relationship between intracellular and extracellular pools of Abeta.
    Oddo S; Caccamo A; Smith IF; Green KN; LaFerla FM
    Am J Pathol; 2006 Jan; 168(1):184-94. PubMed ID: 16400022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.
    Cheng X; Wu J; Geng M; Xiong J
    Neurobiol Aging; 2014 Jun; 35(6):1217-32. PubMed ID: 24368087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.
    Askanas V; Engel WK
    Curr Opin Neurol; 2002 Oct; 15(5):525-31. PubMed ID: 12351995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
    Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
    Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological changes induced by amyloid-β in Alzheimer's disease].
    Takata K; Kitamura Y; Taniguchi T
    Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.